BioBeats develops evidence-based wellbeing products and a workforce wellbeing management platform that combine biometric and psychometric feedback from wearables and smartphones with machine learning to deliver personalized stress and productivity tools. Its flagship app, BioBase, enables users to track, manage and control stress and identify personal stress triggers. The company has built a wearable solution, a secure API and a cloud platform ready to scale, and cites clinical trials with BUPA, AXA and the Center for Digital Economy at the University of Surrey. BioBeats has received UK government awards via InnovateUK and has academic validation published in Frontiers of Human Neuroscience (January 2017). The team emphasizes its AI-driven, science-backed approach and plans to expand product capabilities and global reach. The company recently closed a £2.4M funding round to support further development and scaling. BioBeats operates a biometric machine-learning platform that ingests data from wearables and smartphones to deliver stress and wellbeing insights to healthcare providers and employers. The company uses heart rate, skin conductance, movement and behavior to build an emotional picture of stress and design personalized coaching programs. Its Hear and Now app produces adaptive visuals and music in real time from wrist-worn wearable data to coach users and aims to replace human therapists for detecting stress, fatigue and burnout. The platform can integrate with HR systems and productivity suites to deliver workforce wellbeing and productivity insights and is running pilot programs in major U.K. and U.S. companies. BioBeats plans to roll Hear and Now out to both consumer and corporate wellness markets following the raise. The company raised $2.28M led by White Cloud Capital, with participation from AXA Strategic Ventures and IQ Capital. Founded in 2013 by Dr. David Plans, Nadeem Kassam and David Morelli. BioBeats builds a platform that collects and analyzes physiological signals from wearables and converts those signals into adaptive media—custom music and playlists that react in real time to a user’s body. Its first product, Pulse, detects heartbeat via an iPhone camera and plays music to match activity level; it plans to release BioMuse to build playlists from body signals. The company intends to be device-agnostic, ingesting data from phones, FitBit, FuelBand, UP and other sensors. BioBeats is developing both consumer iOS/Android apps that generate or select music and a clinical app aimed at hospitals. It is exploring revenue from consumer app sales and data-based models sold to insurers and medical customers. The company has used its seed financing to expand the team, including hiring Kristin Shine, M.D., as Chief Medical Officer.

Total raised

$6M

Funding rounds

3

Latest round

Equity

Latest activity

Aug 2018